Independent health economics & outcomes research
Evidence that holds up
when it is challenged.
Built on decades of experience across healthcare delivery, payer analytics, and life sciences research, Pharmatiya transforms complex real-world data into credible clinical and economic evidence that informs treatment decisions, demonstrates value, and strengthens market access strategies.
Hover the curve, or focus it and use the arrow keys, to read either arm.
Fig. 01 / Survival estimate
24-month follow-up
Two arms, separating from month 6 and not converging. Illustrative data.
01The record
- 25+
- years in HEOR, RWE, and outcomes research
- 50
- publications, abstracts, and posters, 2003–2022
- 15
- full publications, including JAMA and Circulation
- 12
- therapeutic areas in the published record
Evidence is only useful when someone can defend it.
A result that cannot survive a payer's methodologist is not a result. We design for the challenge that comes after the readout — which is why feasibility, the analysis plan, and the interpretation are all done by the same senior team.
02What we do
01
Evidence generation
A protocol, an analysis plan and a result that survives challenge — with feasibility settled before any of it is written.
- Study design and feasibility assessment
- Protocol development
- Survival analysis
Fig. 02 / Adjusted hazard ratios
95% confidence interval
Illustrative data.
02
Real-world data analytics
Cohorts, models, and the code behind them, so the analysis is reproducible rather than a black box.
- SQL extraction across Hadoop, Teradata, and TOAD
- Analysis in SAS and SPSS
- Logistic regression and ANOVA
Fig. 03 / Participant flow
mSToPS randomized trial
Steinhubl et al., JAMA 2018.
03
Access & value strategy
The value case built in the terms a plan actually evaluates, by people who have sat on the payer side of the table.
- Value proposition development
- Value-based and outcomes-based contract design
- Care management program design
Fig. 04 / Cost-effectiveness plane
Bootstrap replicates vs. threshold
Illustrative data.
03Data coverage
Payer, provider, and claims data — for twenty-five years.
If your question sits in one of these sources, we have almost certainly answered a version of it before.
Payer
- Medical claims
- Eligibility
- Formulary
Provider
- EMR
- EHR
- Registry
Claims & pharmacy
- Pharmacy Rx
- Medical
- External lab
04RWE Synopsis
AI-assisted evidence.
Human-reviewed conclusions.
Synopses drafted in hours and reviewed by the researchers who would otherwise have written them. The model drafts; a person signs.
- 01
Feasibility
- 02
Retrospective
- 03
Pragmatic outreach
Human reviewRequired at every stage, before any output leaves the system.
Start with a conversation about the question you are trying to answer.
A 30-minute call with a senior researcher. No sales team.